首页> 外文期刊>Endocrine journal >Targeted next-generation sequencing of thirteen causative genes in Chinese patients with congenital hypothyroidism
【24h】

Targeted next-generation sequencing of thirteen causative genes in Chinese patients with congenital hypothyroidism

机译:中国先天性甲状腺功能减退症患者十三种致病基因的靶向下一代测序

获取原文
获取外文期刊封面目录资料

摘要

To identify the spectrum and prevalence of thirteen causative genes mutations in congenital hypothyroidism (CH) patients, we collected blood samples and extracted genomic DNA of 106 CH patients, and designed a customized targeted next-generation sequencing panel containing 13 CH-causing genes to detect mutations. A total of 132 mutations were identified in 65.09% of patients (69/106) on the following nine genes: DUOX2, TG, TPO, TSHR, TTF1, TTF2, NKX2-5, PAX8 and GNAS. 69.70% (92/132) mutations related to thyroid dyshormonogenesis genes, including DUOX2 (n = 49), TG (n = 35), and TPO (n = 8). 21.21% (28/132) mutations related to thyroid dysgenesis genes, including TSHR (n = 19), TTF1 (n = 5), TTF2 (n = 1), PAX8 (n = 2), and NKX2-5 (n = 1). 9.09% (12/132) mutations related to GNAS, which was associated with thyrotropin resistance. No mutation of THRA, TSHB, IYD or SLC5A5 was detected. Among 69 mutations detected patients, 41 (59.42%) patients were two or more mutations detected, and mutations of 30 (43.48%) patients related to two or three genes. According to the pathomechanism of the mutant genes, 57.97% CH patients were classified as thyroid dyshormonogenesis. Overall, DUOX2, TG and TSHR mutations were the most common genetic defects in Chinese CH patients, and thyroid dyshormonogenesis could be the first genetic etiology of CH in Chinese. Besides, multiple mutations accounts for a part of genetic pathogenesis.
机译:为了确定先天性甲状腺功能减退症(CH)患者的13个致病基因突变的谱图和患病率,我们收集了血样并提取了106位CH患者的基因组DNA,并设计了一个定制的靶向下一代测序小组,其中包含13种引起CH的基因来检测突变。在以下九个基因上,在65.09%的患者(69/106)中鉴定出总共132个突变:DUOX2,TG,TPO,TSHR,TTF1,TTF2,NKX2-5,PAX8和GNAS。 69.70%(92/132)突变与甲状腺功能异常的基因有关,包括DUOX2(n = 49),TG(n = 35)和TPO(n = 8)。 21.21%(28/132)与甲状腺发育不良基因相关的突变,包括TSHR(n = 19),TTF1(n = 5),TTF2(n = 1),PAX8(n = 2)和NKX2-5(n = 1)。 9.09%(12/132)突变与GNAS相关,与促甲状腺素抵抗有关。未检测到THRA,TSHB,IYD或SLC5A5突变。在检测到的69位突变患者中,有41位(59.42%)患者检测到两个或更多突变,其中30位(43.48%)患者的突变与两个或三个基因有关。根据突变基因的致病机理,将57.97%的CH患者分类为甲状腺功能异常。总体而言,DUOX2,TG和TSHR突变​​是中国CH患者最常见的遗传缺陷,而甲状腺功能失常可能是中国CH的第一个遗传病因。此外,多种突变占遗传发病机理的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号